Hinova Pharmaceuticals Inc. (SHA:688302)
China · Delayed Price · Currency is CNY 42.60
+1.98 (4.87%)
At close: Mar 6, 2026
Hinova Pharmaceuticals Market Cap
Hinova Pharmaceuticals has a market cap or net worth of 4.22 billion as of March 6, 2026. Its market cap has increased by 45.00% in one year.
Market Cap
4.22B
Enterprise Value
3.41B
Revenue
20.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
42.60
Market Cap Chart
Since April 12, 2022, Hinova Pharmaceuticals's market cap has increased from 2.98B to 4.22B, an increase of 41.53%. That is a compound annual growth rate of 9.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 4.22B | -13.36% |
| Dec 31, 2025 | 4.87B | 60.11% |
| Dec 31, 2024 | 3.04B | -41.02% |
| Dec 29, 2023 | 5.16B | 29.14% |
| Dec 30, 2022 | 3.99B | 33.95% |
| Apr 12, 2022 | 2.98B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hefei Lifeon Pharmaceutical | 4.55B |
| Innovita Biological Technology | 4.54B |
| Beijing Scitop Bio-tech | 4.32B |
| Zhejiang Shouxiangu Pharmaceutical | 4.31B |
| Zhejiang Wecome Pharmaceutical Company | 3.95B |
| Guanhao Biotech | 3.88B |
| Baolingbao Biology | 3.88B |
| Qingdao Vland Biotech INC. | 3.77B |